|
| |
| | | 68795 | | 15.11.2022 | | Mepha Pharma AG | | | | | | | 14.11.2027 | | | | | | 01.99. | | | | 01.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rivastigmin-Mepha Patch 4.6 mg/24 h | Transdermale Pflaster | (Rivastigmine 6.4 mg) | N06DA03 | CI | | 02 | Rivastigmin-Mepha Patch 9.5 mg/24 h | Transdermale Pflaster | (Rivastigmine 12.8 mg) | N06DA03 | | | 03 | Rivastigmin-Mepha Patch 13.3 mg/24 h | Transdermale Pflaster | (Rivastigmine 19.2 mg) | N06DA03 | |
|
|
|
